These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31746932)

  • 1. Anti-breast cancer activity of resveratrol encapsulated in liposomes.
    Zhao YN; Cao YN; Sun J; Liang Z; Wu Q; Cui SH; Zhi DF; Guo ST; Zhen YH; Zhang SB
    J Mater Chem B; 2020 Jan; 8(1):27-37. PubMed ID: 31746932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.
    Jhaveri A; Deshpande P; Pattni B; Torchilin V
    J Control Release; 2018 May; 277():89-101. PubMed ID: 29522834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of Docetaxel and Resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer.
    Zhang L; Lin Z; Chen Y; Gao D; Wang P; Lin Y; Wang Y; Wang F; Han Y; Yuan H
    Eur J Pharm Sci; 2022 Jul; 174():106199. PubMed ID: 35533965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel resveratrol smart lipids; design, formulation, and biological evaluation of anticancer activity.
    Diab RF; Abdelghany TM; Gad S; Elbakry AM
    J Pharm Pharmacol; 2024 Jun; 76(6):631-645. PubMed ID: 38507715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
    Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
    Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model.
    Cordeiro Pedrosa LR; van Tellingen O; Soullié T; Seynhaeve AL; Eggermont AM; Ten Hagen TL; Verheij M; Koning GA
    Eur J Pharm Biopharm; 2015 Aug; 94():207-19. PubMed ID: 25982691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol loaded polymeric micelles for theranostic targeting of breast cancer cells.
    Gregoriou Y; Gregoriou G; Yilmaz V; Kapnisis K; Prokopi M; Anayiotos A; Strati K; Dietis N; Constantinou AI; Andreou C
    Nanotheranostics; 2021; 5(1):113-124. PubMed ID: 33391978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoliposomes Encapsulated Rapamycin/Resveratrol to Induce Apoptosis and Ferroptosis for Enhanced Colorectal Cancer Therapy.
    Jia M; Tan X; Yuan Z; Zhu W; Yan P
    J Pharm Sci; 2024 Aug; 113(8):2565-2574. PubMed ID: 38768753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-mediated delivery of pixantrone-loaded liposomes decorated with poly(sialic acid)-octadecylamine conjugate for lung cancer treatment.
    Luo X; Hu L; Zheng H; Liu M; Liu X; Li C; Qiu Q; Zhao Z; Cheng X; Lai C; Su Y; Deng Y; Song Y
    Drug Deliv; 2018 Nov; 25(1):1200-1212. PubMed ID: 29791241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-triggered sequential-release liposomes enhance anti-breast cancer efficacy of STS and celastrol-based microemulsion.
    Qu D; Wang L; Qin Y; Guo M; Guo J; Huang M; Liu Y; Liu C; Li H; Chen Y
    Biomater Sci; 2018 Nov; 6(12):3284-3299. PubMed ID: 30346001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phospho-ibuprofen (MDC-917) incorporated in nanocarriers: anti-cancer activity in vitro and in vivo.
    Nie T; Wong CC; Alston N; Aro P; Constantinides PP; Rigas B
    Br J Pharmacol; 2012 Jun; 166(3):991-1001. PubMed ID: 22141583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual drug loaded liposome bearing apigenin and 5-Fluorouracil for synergistic therapeutic efficacy in colorectal cancer.
    Sen K; Banerjee S; Mandal M
    Colloids Surf B Biointerfaces; 2019 Aug; 180():9-22. PubMed ID: 31015105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Liposomal Formulation of Acetyltanshinone IIA for Breast Cancer Therapy.
    Wang Q; Luo M; Wei N; Chang A; Luo KQ
    Mol Pharm; 2019 Sep; 16(9):3873-3886. PubMed ID: 31389706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomal Resveratrol Alleviates Platelet Storage Lesion via Antioxidation and the Physical Buffering Effect.
    Hou J; Xiong W; Shao X; Long L; Chang Y; Chen G; Wang L; Wang Z; Huang Y
    ACS Appl Mater Interfaces; 2023 Oct; 15(39):45658-45667. PubMed ID: 37729093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug.
    Ling L; Ismail M; Du Y; Yao C; Li X
    Int J Pharm; 2019 Apr; 560():246-260. PubMed ID: 30769133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects.
    Lin XM; Shi XX; Xiong L; Nie JH; Ye HS; Du JZ; Liu J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery and apoptosis induction activity of peptide-transferrin targeted mesoporous silica encapsulated resveratrol in MCF-7 cells.
    Li D; Song C; Zhang J; Zhao X
    J Pharm Pharmacol; 2023 Jan; 75(1):49-56. PubMed ID: 36173891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy.
    Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM
    Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer.
    Bai F; Yin Y; Chen T; Chen J; Ge M; Lu Y; Xie F; Zhang J; Wu K; Liu Y
    Int J Nanomedicine; 2018; 13():1327-1339. PubMed ID: 29563790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
    Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
    Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.